AKBLF
ALK-Abello AS - Ordinary Shares - Class B

6
Loading...
Loading...
ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. The firm manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics. The company was founded by Poul Christian Krejner Tejn Barfod on June 9, 1923 and is headquartered in Horsholm, Denmark.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2,753

Frequently Asked Questions

What is Market Cap of ALK-Abello AS - Ordinary Shares - Class B?
What is the 52-week high for ALK-Abello AS - Ordinary Shares - Class B?
What is the 52-week low for ALK-Abello AS - Ordinary Shares - Class B?
What is ALK-Abello AS - Ordinary Shares - Class B stock price today?
What was ALK-Abello AS - Ordinary Shares - Class B stock price yesterday?
What is the PE ratio of ALK-Abello AS - Ordinary Shares - Class B?
What is the Price-to-Book ratio of ALK-Abello AS - Ordinary Shares - Class B?
What is the 50-day moving average of ALK-Abello AS - Ordinary Shares - Class B?
How many employess does ALK-Abello AS - Ordinary Shares - Class B has?

Latest AKBLF News

View
No AKBLF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.